Диссертация (1141258), страница 14
Текст из файла (страница 14)
G., de Charro F. T. Economic evaluation of end stagerenal disease treatment //Health policy. – 1998. – Т. 44. – №. 3. – С. 215-232.68.Drummond MF, Pang F. Transferability of economic evaluation results. In:Drummond MF, McGuire A, editors. Economic evaluation in health care. Mergingtheory with practice. Oxford// Oxford University Press,- №11, - 2005.11269.Drummond, M.F. Methods for the Economic Evaluation of Health CareProgrammes / M.F. Drummond, M.J. Sculpher, G.W.
Torrance. - London: OxfordUniversity Press, 2005 – P. 23-27.70.Duong U, Kalantar-Zadeh K, Molnar MZ, et al. Mortality associated with doseresponse of erythropoiesis-stimulating agents in hemodialysis versus peritoneal dialysispatients. Am J Nephrol. 2012; 35:198-208.71.Durand-zaleski I, Combe C, Lang P: International Study of HealthCareOrganization and Financing for end-stage renal disease in France. Int J HealthCareFinance Econ. 2007; 7(2–3): 171–183.72.Erek E, Sever MS, Akoglu E, et al.: Cost of renal replacement therapy in Turkey.Nephrology (Carlton).
2004; 9(1): 33–38.73.Fukuhara S, Yamazaki C, Hayashino Y, et al.: The organization and financing ofend-stage renal disease treatment in Japan. Int J Health Care Finance Econ.2007; 7(2–3): 217–231.74.Gokal R. Peritoneal dialysis: Global Update // Perit. Dial. Int. 1999. V.19. Suppl.2. P.11-15.75.Gokal R. Peritoneal Dialysis in the 21st Century: An Analysis of CurrentProblems and Future Developments // J Am Soc Nephrol 13: S104–S116, 2002.76.Gomez RA.
Renal disease in Colombia. Ren Fail 2006; 28:643–7.77.Hallinen T, Soini EJ, Martikainen JA, et al.: Costs and quality of life effects ofthe first year of renal replacement therapy in one finnish treatment centre. JMedEcon.2009; 12(2): 136–140.78.Han F, Ye L, Qian J, et al. Social insurance cost of dialysis for patients with endstage renal disease in China.
Presented at the World Congress of Nephrology.2007, Riode Janeiro, Brazil, pp. 179–80.79.Hauch A. T., Lundberg P. W., Paramesh A. S. Laparoscopic Techniques EnablePeritoneal Dialysis in the Difficult Abdomen //JSLS: Journal of the Society ofLaparoendoscopic Surgeons. – 2014. – Т. 18. – №. 4.11380.Hooi L. S. et al. Economic evaluation of centrehaemodialysis and continuousambulatory peritoneal dialysis in Ministry of Health hospitals, Malaysia //Nephrology. –2005.
– Т. 10. – №. 1. – С. 25-32.81.Jansen A.M. et al. for the NECOSAD Study Group. Kidney Int. 2002; Vol. 62:1046-1053.82.Jeloka TK, Upase S, Chitikeshi S, et al.: Monthly cost of three exchanges a dayperitoneal dialysis is same as of thrice a week hemodialysis in self-paying Indianpatients.
Indian J Nephrol. 2012; 22(1): 39–41.83.Jose MD, Johnson DW, Mudge DW, et al.: Peritoneal dialysis practiceinAustralia and New Zealand: a call to action. Nephrology (Carlton).2011; 16(1):19–29.84.Julius M. et al. A comparison of employment rates of patients treated withcontinuous ambulatory peritoneal dialysis vs in-center hemodialysis (Michigan EndStage Renal Disease Study) //Archives of internal medicine. – 1989.
– Т. 149. – №. 4. –С. 839-842.85.Karlberg I., Nyberg G. Cost-effectiveness studies of renal transplantation//International journal of technology assessment in health care. – 1995. – Т. 11. – №. 03.– С. 611-622.86.Kontodimopoulos N, Niakas D: A socio-economic comparison of hemodialysisand peritoneal dialysis in greece. Int J Healthcare Technology and Management.2005;6(3): 296–306.87.Kulikov A., Abdrashitova G. T., Serpik V. G. Cost of illness analysis of dialysisin different regions of Russia // Value in Health.
– 2014. – Т. 17. – №. 3. – С. A292A293.88.Kulikov A., Serpik V. G., Abdrashitova G. “Cost of illness” analysis of chronickidney disease in the entire population of the Russian Federation // Value in Health. –2015. – Т. 18. – №. 3. – С. A187.89.Kusoom V, Lapjaroengwong N. Quality of life of patients with end-stage renaldisease and receiving renal replacement therapy. Vajira Med J 2004; 48:107–15.11490.Lamas Barreiro J, Alonso Suarez M, Saavedra Alonso JA, et al.: Costs and addedvalue of haemodialysis and peritoneal dialysis outsourcing agreements.Nefrologia.2011;31(6): 656–663.91.Lameire N., Biesen W.V., Vanholder R. The role of peritoneal dialysis as fi rstmodality in an integrati ve approach to patients with end-stage renal disease // Perit.Dial. Int.
2000. V.20. Р.134-141.92.Laupacis A. et al. A study of the quality of life and cost-utility of renaltransplantation //Kidney international. – 1996. – Т. 50. – №. 1. – С. 235-242.93.Lee H. et al. Cost analysis of ongoing care of patients with end-stage renaldisease: the impact of dialysis modality and dialysis access //American Journal ofKidney Diseases. – 2002. – Т. 40.
– №. 3. – С. 611-622.94.Liyanage T., Ninomiya T., Jha V., Patrice H.M., Okpechi I., Zhao M., et al.Worldwide access to treatment for end stage kidney disease: a systematic review.Lancet. 2015.95.Maharatanavirosn W. Quality of life of patients with end stage renal disease onhemodialysis and continuous ambulatory peritoneal dialysis [Master’s Thesis]. Salaya:Mahidol, 1999.96.Mehrotra R., Nolph K.D. Current status of peritoneal dalysis in Gokal R., KhannaR., Krediet R.T., Nolph K.D. (eds). Textbook of Peritoneal Dialyasis (ed 2).Dordecht⁄Boston⁄London: Kluwer Academic Publishers 2001.97.Mendelssohn D. C. et al. What do American nephrologists think about dialysismodality selection? //American Journal of Kidney Diseases.
– 2001. – Т. 37. – №. 1. –С. 22-29.98.Mendelssohn D.G., Pierratos A. Reformulati ng the integrated care concept forthe new millennium // Perit. Dial. Int. 2002. V.22. P.5-9.99.Neil N, Guest S, Wong L, et al.: The financial implications for Medicareofgreater use of peritoneal dialysis. ClinTher. 2009; 31(4): 880–888.100. Nissenson A. R. et al. Non-medical factors that impact on ESRD modalityselection //Kidney international.
Supplement. – 1993. – Т. 40. – С. S120-7.115101. Orlando L. A. et al. The chronic kidney disease model: a general purpose modelof disease progression and treatment //BMC medical informatics and decision making. –2011. – Т. 11. – №. 1. – С. 41.102. Ouyang C. J. et al. Comparing the incidence of catheter-related complicationswith straight and coiled Tenckhoff catheters in peritoneal dialysis patients—a singlecenter prospective randomized trial //Peritoneal Dialysis International. – 2015. – Т. 35.– №. 4. – С. 443-449.103. Pacheco A, Saffie A, Torres R, et al. Cost/utility study of peritoneal dialysis andhemodialysis in Chile.
Perit Dial Int 2007; 27:359–63.104. Pacheco A, Saffie A, Torres R, et al.: Cost/Utility study of peritoneal dialysis andhemodialysis in Chile. Perit Dial Int. 2007; 27(3): 359–363.105. Pontoriero G, Pozzoni P, Vecchio LD, et al.: International study of health careorganization and financing for renal replacement therapy in Italy: an evolving reality.Int J Health Care Finance Econ. 2007; 7(2–3): 201–215.106. Prieto I, Bhattacharyya SK, Divino J, Paniagua R. Costs of treating ESRDpatients with various dialysis therapies in Mexico. Presented at the 6th World Congresson Health Economics Copenhagen, Denmark, 2007.107. Richardson D, Ford D, Gilg J, Williams AJ: UK Renal Registry 11th AnnualReport (December 2008).
Chapter 9: Haemoglobin, ferritin and erythropoietin amongstpatients receiving dialysis in the UK in 2007: national and centre-specific analyses.Nephron Clin Pract 2009; 111(suppl 1):c149–c183.108. Pukpobsuk N. Determination of quality of life in endstagerenal disease patientson hemodialysis and continuous ambulatory peritoneal dialysis [Master’s thesis].Salaya: Mahidol, 2001.109. Rutkowski B. Highlights of the epidemiology of renal replacement therapy inCentral and Eastern Europe // Nephrol. Dial. Transplant. 2006. V.21.
P.4-10.110. Restrepo C. A., Buitrago C. A., Holguin C. Implantation of peritoneal cathetersby laparotomy: nephrologists obtained similar results to general surgeons //Internationaljournal of nephrology and renovascular disease. – 2014. – Т. 7. – С. 383.116111. Salonen T, Reina T, Oksa H, et al.: Alternative strategies to evaluate the costeffectiveness of peritoneal dialysis and hemodialysis. IntUrolNephrol.
2007; 39(1):289–298.112. Sanabria M, Blackburn JC, Bhattacharyya S, et al. Hospitalization among dialysispatients in the renal therapy services (RTS) multi-centre network in Colombia. WorldCongress of Nephrology 2007 Book of Abstracts, 2007:198.113. Sandoz MS, Ess SM, Keusch GW, et al.: Prevalence and direct medical costs ofend-stage renal disease in patients with type 2 diabetes mellitus in Switzerland for 2001.Swiss Med Wkly. 2004; 134(31–32): 448–458.114. Sennfalt K., Magnusson M., Carlsson P.
Comparison of hemodialysis andperitoneal dialysis--a cost-utility analysis //Peritoneal Dialysis International. – 2002. –Т. 22. – №. 1. – С. 39-47.115. Shih YC, Guo A, Just PM, et al.: Impact of initial dialysis modality and modalityswitches on Medicare expenditures of end-stage renal disease patients. Kidney Int.2005; 68(1): 319–329.116. Sondhi S, Walker DR. In the UK, an increased utilization of peritoneal dialysistherapy could lead to an increase in the number of patients being treated for renalreplacement therapy.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
